Ka Papahana Hui
ʻO Innovita Biological Technology Co., Ltd. (me kāna mau lālā, hui pū ʻia ʻo "INNOVITA",) he hui biotechnology e kālele ana i ka noiʻi, hoʻomohala, hana a kūʻai aku i nā huahana diagnostic POCT in vitro. Aia ʻo Innovita (Tangshan) , Innovita (Beijing) a me Innovita (Guangzhou).
● Hoʻokumu ʻia i ka makahiki 2006
● Hoʻonohonoho i nā kikowaena R&D ma Beijing a me Guangzhou, a me kahi kahua hana ma Qianʻan, Hebei
Ka Papahana Hui
Hoʻokumu ʻia i ka makahiki 2006, ua kūkulu ʻo INNOVITA i ʻeono mau kahua ʻenehana e like me ka antigen & antibody preparation, virus culture, colloidal gold, ELISA, fluorescence chromatography, immunofluorescence, a hoʻokō i ka papahana R&D National High-tech R&D ma ke kahua o ka noiʻi ʻana i nā maʻi infectious nui a me nā mea he nui. nā papahana olakino ʻē aʻe.Ma waho aʻe, ua ʻoi aku ka INNOVITA ma mua o ʻumi mau palapala hoʻokalakupua aupuni a hoʻonohonoho i ke kikowaena R&D o Beijing, ke kikowaena R&D ʻo Guangzhou, ka waihona hana Hebei.Me nā papa hana maʻemaʻe nui, a me ka hoʻonohonoho ʻana i ke gula colloidal, ELISA, fluorescence chromatography, PCR, immunofluorescence production lines, INNOVITA i loaʻa iā CE a me ISO13485 hōʻoia.
I kēia manawa, loaʻa nā huahana INNOVITA i nā ho'āʻo maʻi hanu, nā ho'āʻo fertility, nā ho'āʻo hepatitis, nā ho'āʻo TORCH, nā hoʻokolohua cardiovascular, nā ho'āʻo hana renal a pēlā aku.Ua uhi ʻia ka ʻoihana kūʻai aku i nā panalāʻau a me nā ʻāina āpau ma Kina, a hoʻolaha i ka Hikina Hema, ka Middle East, Africa, Latin America, European Union a me nā ʻāina ʻē aʻe.Hoʻopili ʻo INNOVITA i ka manaʻo ʻoihana pili i ka mea kūʻai aku, a lawelawe i nā mea kūʻai aku me nā huahana pololei a maʻalahi.ʻO nā pono o nā mea kūʻai aku ka ʻimi ʻana o INNOVITA.
Kaʻina Hoʻomohala
Nā lālā
ʻO Beijing R&D & Marketing Center
Hoʻokumu:2006
Nānā:R&D, hana, kūʻai aku i nā huahana diagnostic in-vitro, me nā paepae e like me immunodiagnosis, molecular diagnostic, a me nā ʻāpana gene.
Qian'an Manufacturing & Logistic Center
Hoʻokumu:2011
Mea hana:E uhi ana i kahi o 150 mau ʻeka, ma kahi o 8,000 ㎡ kahi papa hana, i lako me nā laina hana he nui o ke gula colloidal, ELISA, PCR.
palapala hōʻoia:ISO 13485, CE, FDA, NMPA, etc.
ʻO Guangzhou R&D Center
Hoʻokumu:2020
Nānā:R&D o nā ʻenehana IVD
Nā paepae
Pūnaehana Kūʻai
Ma hope o nā makahiki o ka hoʻomohala ʻana, ua loaʻa iā Innovita kahi ʻoihana kūʻai a me ka lawelawe lawelawe, me nā ala kūʻai e uhi ana i 32 mau panalāʻau a me nā ʻāpana ma Kina, a ua lawe aku i nā mākeke honua e like me Asia Hikina Hema, Middle East, Africa, Latin America, Europe, etc.
Hōʻike ʻia ka hōʻike ʻo Innovita 2019-nCoV Ab ma ka paepae pilikia o ka ʻāina no nā lāʻau lapaʻau a me nā mea lapaʻau
Ma ka lā 28 o Pepeluali, 2020, ua nānā ʻo Premier Li Keqiang i ke kahua hoʻokele ulia pōpilikia no nā lāʻau lapaʻau a me nā mea lapaʻau o COVID-19.Ua hōʻike ʻia ʻo Innovita 2019-nCoV Ab Test ma ke ʻano he NMPA i ʻae ʻia i ka IgM/IgG combo antibody test, i hōʻike ʻia ma CCTV.
ʻO ka hōʻike ʻo Innovita 2019-nCoV Ab i kapa ʻia e Academician Zhong Nanshan
● Ma ka ʻauinalā o Pepeluali 23, 2020, ua hōʻike ʻo Academician Zhong Nanshan i ka wā kūkākūkā mamao ma Guangzhou me ka hui lapaʻau Guangdong e holo wikiwiki ana e kōkua iā Jingzhou ua ʻae ka National Medical Products Administration i ʻelua mau pahu hoʻāʻo hou no 2019-nCoV, ʻo ia kekahi. hana ʻia e Innovita (Tangshan) Biological Technology Co., Ltd.
● Hoʻohana ka pahu i ke ʻano gula colloidal, hiki ke ʻike i ka antibody lgM i loko o ke kino o ka mea maʻi.Hiki ke ʻike ʻia ka antibody lgM ma ka lā 7 o ka maʻi o ka mea maʻi a i ʻole ka lā 3 o ka hoʻomaka ʻana, he mea kōkua nui ia no ka ʻike hou ʻana o ka mea maʻi.Ua ʻōlelo ʻo Zhong Nanshan: "Hiki ke ʻike koke ʻia nā maʻi no kahi maʻi maʻi.